The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Cellular and molecular actions of Methylene Blue in the nervous system
Open accessAbstract
Methylene Blue (MB), following its introduction to biology in the 19th century by Ehrlich, has found uses in various areas of medicine and biology. At present, MB is the first line of treatment in methemoglobinemias, is used frequently in the treatment of ifosfamide‐induced encephalopathy, and is routinely employed as a diagnostic tool in surgical procedures. Furthermore, recent studies suggest that MB has beneficial effects in Alzheimer's disease and memory improvement. Although the modulation of the cGMP pathway is considered the most significant effect of MB, mediating its pharmacological actions, recent studies indicate that it has multiple cellular and molecular targets. In the majority of cases, biological effects and clinical applications of MB are dictated by its unique physicochemical properties including its planar structure, redox chemistry, ionic charges, and light spectrum characteristics. In this review article, these physicochemical features and the actions of MB on multiple cellular and molecular targets are discussed with regard to their relevance to the nervous system. © 2009 Wiley Periodicals, Inc. Med Res Rev, 31, No. 1, 93–117, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-6-487_2 · Cited by 4,500
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739
A Century of Alzheimer's Disease
Goedert, M., & Spillantini, M. G. (2006) · Science · doi:10.1126/science.1132814 · Cited by 2,098
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Methylene blue in photodynamic therapy: From basic mechanisms to clinical applications
Tardivo, J. P., Del Giglio, A., de Oliveira, C. S., Gabrielli, D. S., Junqueira, H. C., Tada, D. B., Severino, D., de Fátima Turchiello, R., & Baptista, M. S. (2005) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/s1572-1000(05)00097-9 · Cited by 917
Photodynamic Therapy in Oncology
Triesscheijn, M., Baas, P., Schellens, J. H. M., & Stewart, F. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-9-1034 · Cited by 737
Greig, N. H., Utsuki, T., Ingram, D. K., Wang, Y., Pepeu, G., Scali, C., Yu, Q.-S., Mamczarz, J., Holloway, H. W., Giordano, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508575102 · Cited by 734
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease
Korth, C., May, B. C. H., Cohen, F. E., & Prusiner, S. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161274798 · Cited by 673
Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds
Hassan, H. M., & Fridovich, I. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90289-3 · Cited by 596
Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines.
Wischik, C. M., Edwards, P. C., Lai, R. Y., Roth, M., & Harrington, C. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11213 · Cited by 547
Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins
Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S.-I., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540
Inhibition of nitric oxide synthesis by methylene blue
Mayer, B., Brunner, F., & Schmidt, K. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90072-5 · Cited by 535
Radic, Z., Pickering, N. A., Vellom, D. C., Camp, S., & Taylor, P. (1993) · Biochemistry · doi:10.1021/bi00096a018 · Cited by 437
Tau, tangles, and Alzheimer's disease
Binder, L. I., Guillozet-Bongaarts, A. L., Garcia-Sierra, F., & Berry, R. W. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.08.014 · Cited by 434
The creation of psychopharmacology
(2002) · Choice Reviews Online · doi:10.5860/choice.40-0332 · Cited by 423
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Methylene Blue - a Therapeutic Dye for All Seasons?
Wainwright, M., & Crossley, K. B. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.5.431 · Cited by 396
The Utility of Superoxide Dismutase in Studying Free Radical Reactions
McCord, J. M., & Fridovich, I. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)63246-6 · Cited by 388
The Creation of Psychopharmacology
Healy, D. (2002) · Harvard University Press eBooks · doi:10.4159/9780674038455 · Cited by 388
Pharmacokinetics and organ distribution of intravenous and oral methylene blue
Peter, C., Hongwan, D., Küpfer, A., & Lauterburg, B. H. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000124 · Cited by 373
Cholinesterases: New Roles in Brain Function and in Alzheimer's Disease
Giacobini, E. (2003) · Neurochemical Research · doi:10.1023/a:1022869222652 · Cited by 371
The Collected Papers of Paul Ehrlich
(2013) · Elsevier eBooks · doi:10.1016/c2013-0-01635-0 · Cited by 365
Tuite, E. M., & Kelly, J. M. (1993) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/1011-1344(93)80173-7 · Cited by 325
Clifton, J., & Leikin, J. B. (2003) · American Journal of Therapeutics · doi:10.1097/00045391-200307000-00009 · Cited by 318
Goodman and Gilman's The Pharmacological Basis of Therapeutics.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-6-826_1 · Cited by 305
Alzheimer disease, the two-hit hypothesis: An update
Zhu, X., Lee, H.-G., Perry, G., & Smith, M. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292
Ramsay, R. R., Dunford, C., & Gillman, P. K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707430 · Cited by 276
A history of antipsychotic drug development
Shen, W. W. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90082-2 · Cited by 273
Methylene Blue Delays Cellular Senescence and Enhances Key Mitochondrial Biochemical Pathways
Atamna, H., Nguyen, A., Schultz, C., Boyle, K., Newberry, J., Kato, H., & Ames, B. N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9610com · Cited by 272
Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial
Collinge, J., Gorham, M., Hudson, F., Kennedy, A., Keogh, G., Pal, S., Rossor, M., Rudge, P., Siddique, D., Spyer, M., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70049-3 · Cited by 262
Amyloid–cholinesterase interactions: Implications for Alzheimer’s disease
Inestrosa, N. C., Dinamarca, M. C., & Alvarez, A. (2008) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.06238.x · Cited by 261
Methylene blue and Alzheimer's disease
Oz, M., Lorke, D. E., & Petroianu, G. A. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.034 · Cited by 257
Self-citationPelgrims, J., De Vos, F., Van den Brande, J., Schrijvers, D., Prové, A., & Vermorken, J. B. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0917 · Cited by 242
Kocisko, D. A., Baron, G. S., Rubenstein, R., Chen, J., Kuizon, S., & Caughey, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10288-10294.2003 · Cited by 231
Methylene blue as an inhibitor of superoxide generation by xanthine oxidase
Salaris, S. C., Babbs, C. F., & Voorhees, W. D. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90311-r · Cited by 223
Targeting acetylcholinesterase to treat neurodegeneration
Holzgrabe, U., Kapková, P., Alptüzün, V., Scheiber, J., & Kugelmann, E. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.2.161 · Cited by 217
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Photoöxidation of amino acids in the presence of methylene blue
Weil, L., Gordon, W. G., & Buchert, A. R. (1951) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(51)90084-7 · Cited by 206
The effect of rotenone on respiration and its point of attack
Lindahl, P. E., & Öberg, K. E. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90033-7 · Cited by 202
Nitric oxide increases dopamine and serotonin release in the medial preoptic area
Lorrain, D. S., & Hull, E. M. (1993) · NeuroReport · doi:10.1097/00001756-199310000-00024 · Cited by 200
Adverse Effects of Methylene Blue on the Central Nervous System
Vutskits, L., Briner, A., Klauser, P., Gascon, E., Dayer, A. G., Kiss, J. Z., Muller, D., Licker, M. J., & Morel, D. R. (2008) · Anesthesiology · doi:10.1097/aln.0b013e3181684be4 · Cited by 187
Vasoplegic syndrome—the role of methylene blue
SHANMUGAM, G. (2005) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2005.07.011 · Cited by 187
Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blue
Küpfer, A., Aeschlimann, C., Wermuth, B., & Cerny, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91839-2 · Cited by 178
Cyanide poisoning and its treatment
Gracia, R., & Shepherd, G. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.14.1358.43149 · Cited by 173
Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo
Wegener, G., Volke, V., & Rosenberg, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703349 · Cited by 167
Buchholz, K., Schirmer, R. H., Eubel, J. K., Akoachere, M. B., Dandekar, T., Becker, K., & Gromer, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00773-07 · Cited by 163
Occupational Methaemoglobinaemia
Bradberry, S. M. (2003) · Toxicological Reviews · doi:10.2165/00139709-200322010-00003 · Cited by 161
Wolin, M. S., Cherry, P. D., Rodenburg, J. M., Messina, E. J., & Kaley, G. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12689-x · Cited by 158
Volke, V., Wegener, G., Bourin, M., & Vasar, E. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00312-1 · Cited by 157
Marczin, N., Ryan, U. S., & Catravas, J. D. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10320-0 · Cited by 150
DiSanto, A. R., & Wagner, J. G. (1972) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600610710 · Cited by 145
STUDIES ON OXIDATION-REDUCTION
Ball, E. G., Chen, T.-T., & Clark, W. M. (1933) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50198-8 · Cited by 143
In Vitro Photodynamic Activity of a Series of Methylene Blue Analogues¶
Mellish, K. J., Cox, R. D., Vernon, D. I., Griffiths, J., & Brown, S. B. (2002) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2002)0750392ivpaoa2.0.co2 · Cited by 142
Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer Disease
Nordberg, A. K. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213804.59187.2d · Cited by 137
Dhir, A., & Kulkarni, S. K. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.028 · Cited by 133
Coulibaly, B., Zoungrana, A., Mockenhaupt, F. P., Schirmer, R. H., Klose, C., Mansmann, U., Meissner, P. E., & Müller, O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005318 · Cited by 133
Hope in Alzheimer's fight emerges from unexpected places
Gura, T. (2008) · Nature Medicine · doi:10.1038/nm0908-894 · Cited by 123
Methylene blue improves brain oxidative metabolism and memory retention in rats
Callaway, N. L., Riha, P. D., Bruchey, A. K., Munshi, Z., & Gonzalez-Lima, F. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.007 · Cited by 121
Methylene blue prevents neurodegeneration caused by rotenone in the retina
Zhang, X., Rojas, J. C., & Gonzalez-Lima, F. (2006) · Neurotoxicity Research · doi:10.1007/bf03033307 · Cited by 118
Wischik, C. M., Bentham, P., Wischik, D., & Seng, K. M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.438 · Cited by 118
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Lorke, D. E., Lü, G., Cho, E. Y. P., & Yew, D. T. W. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-36 · Cited by 117
Self-citationANXIOLYTIC AND ANTIDEPRESSANT PROPERTIES OF METHYLENE BLUE IN ANIMAL MODELS
Eroǧlu, L., & Çağlayan, B. (1997) · Pharmacological Research · doi:10.1006/phrs.1997.0245 · Cited by 114
Ajithkumar, T., Parkinson, C., Shamshad, F., & Murray, P. A. (2006) · Clinical Oncology · doi:10.1016/j.clon.2006.11.003 · Cited by 114
Deiana, S., Harrington, C. R., Wischik, C. M., & Riedel, G. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1394-2 · Cited by 108
Stimulation of respiration by methylene blue in rat liver mitochondria
Visarius, T. M., Stucki, J. W., & Lauterburg, B. H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00767-9 · Cited by 104
Photo-Induced Destruction of Giant Vesicles in Methylene Blue Solutions
Caetano, W., Haddad, P. S., Itri, R., Severino, D., Vieira, V. C. C., Baptista, M. S., Schröder, A., & Marques, C. M. (2006) · Langmuir · doi:10.1021/la061510v · Cited by 102
L-arginine induces dopamine release from the striatum in vivo
Strasser, A., McCarron, R. M., Ishii, H., Stanimirovic, D. B., & Spatz, M. (1994) · Neuroreport · doi:10.1097/00001756-199411000-00023 · Cited by 102
Naylor, G. J., Martin, B., Hopwood, S. E., & Watson, Y. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90265-9 · Cited by 96
Extinction Memory Improvement by the Metabolic Enhancer Methylene BluePreprint
Gonzalez-Lima, F., & Bruchey, A. K. (2004) · Learning & Memory · doi:10.1101/lm.82404 · Cited by 93
The cell cycle as a therapeutic target for Alzheimer's disease
Neve, R. L., & McPhie, D. L. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.005 · Cited by 92
Riha, P. D., Bruchey, A. K., Echevarria, D. J., & Gonzalez-Lima, F. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.02.001 · Cited by 92
Cyclic GMP and cell death in rat cerebellar slices
Garthwaite, G., & Garthwaite, J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90148-0 · Cited by 91
Callaway, N. L., Riha, P. D., Wrubel, K. M., McCollum, D., & Gonzalez-Lima, F. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00827-3 · Cited by 90
Effects of methylene blue and LY83583 on neuronal nitric oxide synthase and NADPH-diaphorase
Luo, D., Das, S., & Vincent, S. R. (1995) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(95)00084-4 · Cited by 89
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's disease
Geula, C., & Darvesh, S. (2004) · Drugs of today · doi:10.1358/dot.2004.40.8.850473 · Cited by 88
The pattern of cutaneous innervation in relation to cutaneous sensibility.
Weddell, G. (1941) · PubMed · Cited by 87
The use of dyes in modern biomedicine
WAINWRIGHT, M. S. (2003) · Biotechnic & Histochemistry · doi:10.1080/10520290310001602404 · Cited by 87
Methylene Blue–Induced Heinz Body Hemolytic Anemia
Sills, M. R. (1994) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1994.02170030076017 · Cited by 86
Monitoring pathological assembly of tau and ?-amyloid proteins in Alzheimer's disease
Mena, R., Edwards, P., P�rez-Olvera, O., & Wischik, C. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00294259 · Cited by 85
Jejunal atresia related to the use of methylene blue in genetic amniocentesis in twins
van der Pol, J. G., WOLF, H., Boer, K., Treffers, P. E., Leschot, N. J., HEY, H. A., & VOS, A. (1992) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14473.x · Cited by 85
The discovery of dendritic spines by Cajal in 1888 and its relevance in the present neuroscience
García-López, P., García‐Marín, V., & Freire, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.002 · Cited by 84
Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria
Rengelshausen, J., Burhenne, J., Fr�hlich, M., Tayrouz, Y., Singh, S. K., Riedel, K., M�ller, O., Hoppe‐Tichy, T., Haefeli, W. E., Mikus, G., et al. (2004) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-004-0818-0 · Cited by 84
A controlled trial of methylene blue in severe depressive illness
Naylor, G. J., Smith, A. H. W., & Connelly, P. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90194-6 · Cited by 75
Riedel, W., Lang, U., Oetjen, U., Schlapp, U., & Shibata, M. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024142400835 · Cited by 74
Aeschlimann, C., Cerny, T., & Kupfer, A. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08471-5 · Cited by 71
Ferreira, S. H., & Lorenzetti, B. B. (1996) · Inflammation Research · doi:10.1007/bf02311085 · Cited by 68
Neurological sequelae following methylene blue injection for parathyroidectomy
Martindale, S. J., & Stedeford, J. C. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03415_23.x · Cited by 67
Methylene blue inhibits hippocampal nitric oxide synthase activity in vivo
Volke, V., Wegener, G., Vasar, E., et al. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01253-6 · Cited by 65
Potential of Methylene Blue to Block Oxygen Radical Generation in Reperfusion Injury
Kelner, M. J., Bagnell, R. D., Hale, B., & Alexander, N. M. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5568-7_146 · Cited by 63
Deutsch, S. I., Rosse, R. B., Paul, S. M., Tomasino, V., Koetzner, L., Morn, C. B., & Mastropaolo, J. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00153-5 · Cited by 63
Phenothiazines: potential management of Creutzfeldt–Jacob disease and its variants
Amaral, L., & Kristiansen, J. E. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00432-0 · Cited by 63
Stanford, S. C., Stanford, B. J., & Gillman, P. K. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109105450 · Cited by 62
The interaction between methylene blue and the cholinergic system
Pfaffendorf, M., Bruning, T. A., Batink, H. D., & van Zwieten, P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701355 · Cited by 62
Methylene Blue Adjuvant Therapy of Schizophrenia
Deutsch, S. I., Rosse, R. B., Schwartz, B. L., Fay-McCarthy, M., Rosenberg, P. B., & Jones-Fearing, K. B. (1997) · Clinical Neuropharmacology · doi:10.1097/00002826-199708000-00008 · Cited by 61
Narsapur (1983) · doi:10.1016/0165-0327(83)90008-3 · Cited by 59
Darvesh, S., McDonald, R. S., Penwell, A., Conrad, S., Darvesh, K. V., Mataija, D., Gomez, G., Caines, A., Walsh, R., & Martin, E. V. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.059 · Cited by 59
Methylene-Blue–Associated Encephalopathy
Sweet, G., & Standiford, S. B. (2007) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.12.030 · Cited by 59
Simulation of Na channel inactivation by thiazine dyes.
Armstrong, C. M., & Croop, R. S. (1982) · The Journal of General Physiology · doi:10.1085/jgp.80.5.641 · Cited by 59
The brain metabolic enhancer methylene blue improves discrimination learning in rats
Wrubel, K. M., Riha, P. D., Maldonado, M. A., McCollum, D., & Gonzalez-Lima, F. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.02.018 · Cited by 58
Choline Redistribution during Adaptation to Choline Deprivation
Li, Z., Agellon, L. B., & Vance, D. E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611726200 · Cited by 56
Minami, T., Nishihara, I., Ito, S., Sakamoto, K., Hyodo, M., & Hayaishi, O. (1995) · Pain · doi:10.1016/0304-3959(94)00183-f · Cited by 55
Darvesh, S., McDonald, R. S., Darvesh, K. V., Mataija, D., Conrad, S., Gomez, G., Walsh, R., & Martin, E. V. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.06.060 · Cited by 53
Hattori, M., Sugino, E., Minoura, K., In, Y., Sumida, M., Taniguchi, T., Tomoo, K., & Ishida, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.001 · Cited by 53
Ng, B., Cameron, A. J. D., Liang, R., & Rahman, H. U. (2008) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03017595 · Cited by 51
Methylene Blue by Intraosseous Infusion for Methemoglobinemia
Herman, M. I., Chyka, P. A., Butler, A. Y., & Rieger, S. E. (1999) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(99)70427-0 · Cited by 51
Methylene blue alters retention of inhibitory avoidance responses
Martinez, J. L., Jensen, R. A., Vásquez, B. J., McGuinness, T. L., & McGaugh, J. L. (1978) · Physiological Psychology · doi:10.3758/bf03326744 · Cited by 50
Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum
Furian, A. F., Fighera, M. R., Oliveira, M. S., Ferreira, A. P. D. O., Fiorenza, N. G., Myskiw, J. D. C., Petry, J. C., Coelho, R. C., Mello, C. F., & Royes, L. F. F. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.07.012 · Cited by 50
Luna‐Muñoz, J., Peralta‐Ramirez, J., Chávez-Macías, L., Harrington, C. R., Wischik, C. M., & Mena, R. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0431-x · Cited by 50
Neurosyphilis, Malaria, and the Discovery of Antipsychotic Agents
Frankenburg, F. R., & Baldessarini, R. J. (2008) · Harvard Review of Psychiatry · doi:10.1080/10673220802432350 · Cited by 47
Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter
de-Oliveira, R. W., & Guimarães, F. S. (1999) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x1999001200012 · Cited by 46
Spilman, P., Lessard, P., Sattavat, M., Bush, C., Tousseyn, T., Huang, E. J., Giles, K., Golde, T. E., Das, P., Fauq, A. H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803671105 · Cited by 45
Kristiansen, J. E. (1989) · PubMed · Cited by 45
A Multimeric Quinacrine Conjugate as a Potential Inhibitor of Alzheimer's β‐Amyloid Fibril Formation
Dolphin, G. T., Chierici, S., Ouberai, M. M., Dumy, P., & Garcia, J. (2008) · ChemBioChem · doi:10.1002/cbic.200700602 · Cited by 44
Ryle, P. R., Chakraborty, J., & Thomson, A. D. (1985) · Biochemical Journal · doi:10.1042/bj2320877 · Cited by 41
May, J. M., Qu, Z., & Whitesell, R. R. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00408-8 · Cited by 40
Phencyclidine‐Induced Behaviour in Mice Prevented by Methylene Blue
Klamer, D., Engel, J. A., & Svensson, L. (2004) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2004.pto940203.x · Cited by 36
Signorini-Allibe, N., Gonthier, B., Lamarche, F., Eysseric, H., & Barret, L. G. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh097 · Cited by 35
Masaki, E., & Kondo, I. (1999) · Anesthesia & Analgesia · doi:10.1097/00000539-199908000-00045 · Cited by 35
Inactivation of the Scrapie Agent by Ultraviolet Irradiation in the Presence of Chlorpromazine
Dees, C., Wade, W. F., German, T. L., & Marsh, R. F. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-4-845 · Cited by 32
Naylor, G. J., Smith, A. H. W., & Connelly, P. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90229-6 · Cited by 31
Methylene blue is a potent monoamine oxidase inhibitor
Gillman, P. K., Ng, B., Cameron, A. J. D., et al. (2008) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03017212 · Cited by 30
Methylene Blue-Associated Serotonin Syndrome: A ‘Green’ Encephalopathy After Parathyroidectomy
Rowley, M., Riutort, K. T., Shapiro, D., Casler, J. D., Festić, E., & Freeman, W. D. (2009) · Neurocritical Care · doi:10.1007/s12028-009-9206-z · Cited by 29
Methylene blue stimulates 2-deoxyglucose uptake in L929 fibroblast cells
Louters, L. L., Dyste, S. G., Frieswyk, D., TenHarmsel, A., Kooy, T. O. V., Walters, L., & Whalen, T. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.082 · Cited by 27
Yücel, Y. Y., Tacal, Ö., & Özer, İ. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.07.006 · Cited by 25
Ehringer, H., Hornykiewicz, O., & Lechner, K. (1961) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf02438625 · Cited by 23
Methylene blue staining for nerve-sparing operative procedures: an animal model
Seif, C., Portillo, F. J. M., Osmonov, D. K., Böhler, G., van der Horst, C., Leissner, J., Hohenfellner, R., Juenemann, K. P., & Braun, P. M. (2004) · Urology · doi:10.1016/j.urology.2003.12.020 · Cited by 22
Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue
Khavandi, A., Whitaker, J., & Gonna, H. (2008) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb02168.x · Cited by 21
Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil
Patil, C. S., Singh, V. P., & Kulkarni, S. K. (2005) · Inflammopharmacology · doi:10.1163/156856005774649359 · Cited by 20
[Treatment of ifosfamide induced encephalopathy with methylene-blue].
Ferrero, J.-M., Eftekari, P., Largillier, R., et al. (1995) · PubMed · Cited by 19
Kress, M., Petersen, M., & Reeh, P. W. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005098 · Cited by 19
Müller, T. (1998) · PubMed · doi:10.14670/hh-13.1019 · Cited by 18
Bardakçı, H., Kaplan, S., Karadeniz, Ü., et al. (2006) · European Surgical Research · doi:10.1159/000096007 · Cited by 15
MEMBRANE POTENTIAL CAN INFLUENCE THE RATE OF MEMBRANE PHOTOMODIFICATION
Valenzeno, D. P., Arriaga, E. A., Trank, J. W., & Tarr, M. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb02961.x · Cited by 13
Learning and Memory in Mice Treated with Choline Oxidase, a Hydrolytic Enzyme for Choline
Ikarashi, Y., Kuribara, H., Shiobara, T., Takahashi, A., Ishimaru, H., & Maruyama, Y. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00223-3 · Cited by 9
Advances in understanding the pathogenetic mechanisms of Alzheimer's disease.
Govoni, S. M., Lanni, C., & Racchi, M. (2001) · PubMed · Cited by 5
Cited by
Review on Methylene Blue: Its Properties, Uses, Toxicity and Photodegradation
Khan, I., Saeed, K., Zekker, I., Zhang, B., Hendi, A. H., Ahmad, A., Ahmad, S., Zada, N., Ahmad, H., Shah, L. A., et al. (2022) · Water · doi:10.3390/w14020242 · Cited by 1,703
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640
Activated lignin-chitosan extruded blends for efficient adsorption of methylene blue
Albadarin, A. B., Collins, M. N., Naushad, M., Shirazian, S., Walker, G., & Mangwandi, C. (2017) · Chemical Engineering Journal · doi:10.1016/j.cej.2016.08.089 · Cited by 796
Mouni, L., Belkhiri, L., Bollinger, J.-C., Bouzaza, A., Assadi, A., Tirri, A., Dahmoune, F., Madani, K., & Remini, H. (2018) · Applied Clay Science · doi:10.1016/j.clay.2017.11.034 · Cited by 712
“Lest we forget you — methylene blue …”
Schirmer, R. H., Adler, H., Pickhardt, M., & Mandelkow, E. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.12.012 · Cited by 414
Metadata
- Authors
- Oz, M., Lorke, D. E., Hasan, M., & Petroianu, G. A.
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2010-12-13
- Volume
- 31
- Issue
- 1
- Pages
- 93-117
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- OpenAlex
- W2081058092
- Cited by
- 443
- References
- 136
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.